Schedule 13G ownership disclosure

Sagimet Biosciences Inc

Security class unavailable · CUSIP: 786700104

Event date: 2024-09-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
724,800
Percent of class
2.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-24-006615
Form type
SC 13G
Filer
HILLHOUSE INVESTMENT MANAGEMENT, LTD.
CIK
CIK 1510589
Filed
Nov 14, 2024
Reporting period
Sep 30, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub